The Director General of the World Health Organisation, Dr Tedros Ghebreyesus, on Tuesday, announced plans to establish a new TB Vaccine Accelerator Council.
Dr Ghebreyesus, who said this at a high-level panel on TB at the World Economic Forum, noted that the adverse impact of the COVID-19 pandemic on tuberculosis services had brought the urgency of vaccine development efforts into sharp focus.
He said the Council would facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments, and end users in identifying and overcoming barriers to the TB vaccine development.
“One of the most important lessons from the response to the COVID-19 pandemic is that innovative health interventions can be delivered fast if they are prioritised politically and financed adequately,” said Ghebreyesus.
“The challenges presented by TB and COVID-19 are different, but the ingredients that accelerate science, research, and innovation are the same: urgent, up-front public investment; support from philanthropy; and engagement of the private sector and communities. We believe the TB field will benefit from similar high-level coordination,” he added.